The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials
Open accessAbstract
Summary Background For patients with end-stage renal disease who are not candidates for fistula, dialysis access grafts are the best option for chronic haemodialysis. However, polytetrafluoroethylene arteriovenous grafts are prone to thrombosis, infection, and intimal hyperplasia at the venous anastomosis. We developed and tested a bioengineered human acellular vessel as a potential solution to these limitations in dialysis access. Methods We did two single-arm phase 2 trials at six centres in the USA and Poland. We enrolled adults with end-stage renal disease. A novel bioengineered human acellular vessel was implanted into the arms of patients for haemodialysis access. Primary endpoints were safety (freedom from immune response or infection, aneurysm, or mechanical failure, and incidence of adverse events), and efficacy as assessed by primary, primary assisted, and secondary patencies at 6 months. All patients were followed up for at least 1 year, or had a censoring event. These trials are registered with ClinicalTrials.gov, NCT01744418 and NCT01840956. Findings Human acellular vessels were implanted into 60 patients. Mean follow-up was 16 months (SD 7·6). One vessel became infected during 82 patient-years of follow-up. The vessels had no dilatation and rarely had post-cannulation bleeding. At 6 months, 63% (95% CI 47–72) of patients had primary patency, 73% (57–81) had primary assisted patency, and 97% (85–98) had secondary patency, with most loss of primary patency because of thrombosis. At 12 months, 28% (17–40) had primary patency, 38% (26–51) had primary assisted patency, and 89% (74–93) had secondary patency. Interpretation Bioengineered human acellular vessels seem to provide safe and functional haemodialysis access, and warrant further study in randomised controlled trials. Funding Humacyte and US National Institutes of Health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931
Functional Arteries Grown in Vitro
Niklason, L. E., Gao, J., Abbott, W. M., Hirschi, K. K., Houser, S., Marini, R., & Langer, R. (1999) · Science · doi:10.1126/science.284.5413.489 · Cited by 1,766
Self-citationHofstra, L., Tordoir, J. H. M., Kitslaar, P. J. E. H. M., Hoeks, A. P. G., & Daemen, M. J. A. P. (1996) · Circulation · doi:10.1161/01.cir.94.6.1283 · Cited by 1,603
Recommended standards for reports dealing with arteriovenous hemodialysis accesses
Sidawy, A. N., Gray, R., Besarab, A., Henry, M., Ascher, E., Silva, M., Miller, A., Scher, L., Trerotola, S., Gregory, R. T., et al. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.122025 · Cited by 904
Allahverdian, S., Chehroudi, A. C., McManus, B. M., Abraham, T., & Francis, G. A. (2014) · Circulation · doi:10.1161/circulationaha.113.005015 · Cited by 748
Readily Available Tissue-Engineered Vascular Grafts
Dahl, S. L. M., Kypson, A. P., Lawson, J. H., Blum, J. L., Strader, J. T., Li, Y., Manson, R. J., Tente, W. E., DiBernardo, L., Hensley, M. T., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001426 · Cited by 563
Self-citationMcAllister, T. N., Maruszewski, M., Garrido, S. A., Wystrychowski, W., Dusserre, N., Marini, A., Zagalski, K., Fiorillo, A., Avila, H., Manglano, X., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60248-8 · Cited by 511
Frid, M. G., Brunetti, J. A., Burke, D. L., Carpenter, T. C., Davie, N. J., Reeves, J. T., Roedersheimer, M. T., van Rooijen, N., & Stenmark, K. R. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050599 · Cited by 449
Creation Of Viable Pulmonary Artery Autografts Through Tissue Engineering
Shinoka, T., Shum-Tim, D., Ma, P. X., Tanel, R. E., Isogai, N., Langer, R., Vacanti, J. P., & Mayer, J. E. (1998) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70315-0 · Cited by 444
Stent Graft versus Balloon Angioplasty for Failing Dialysis-Access Grafts
Haskal, Z. J., Trerotola, S., Dolmatch, B., Schuman, E., Altman, S., Mietling, S., Berman, S., McLennan, G., Trimmer, C., Ross, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0902045 · Cited by 422
Cited by
Vascular Tissue Engineering: Progress, Challenges, and Clinical Promise
Song, H.-H. G., Rumma, R. T., Ozaki, C. K., Edelman, E. R., & Chen, C. S. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.02.009 · Cited by 476
Neishabouri, A., Soltani Khaboushan, A., Daghigh, F., Kajbafzadeh, A.-M., & Majidi Zolbin, M. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.805299 · Cited by 281
Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity
Fioretta, E. S., Motta, S. E., Lintas, V., Loerakker, S., Parker, K. K., Baaijens, F. P. T., Falk, V., Hoerstrup, S. P., & Emmert, M. Y. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0422-8 · Cited by 262
Radke, D., Jia, W., Sharma, D., Fena, K., Wang, G., Goldman, J., & Zhao, F. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701461 · Cited by 256
A review on fabricating tissue scaffolds using vat photopolymerization
Chartrain, N. A., Williams, C. B., & Whittington, A. R. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.05.010 · Cited by 253
Metadata
- Authors
- Lawson, J. H., Glickman, M. H., Ilzecki, M., Jakimowicz, T., Jaroszynski, A., Peden, E. K., Pilgrim, A. J., Prichard, H. L., Guziewicz, M., Przywara, S., Szmidt, J., Turek, J., Witkiewicz, W., Zapotoczny, N., Zubilewicz, T., & Niklason, L. E.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 387
- Issue
- 10032
- Pages
- 2026-2034
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2362125499
- Cited by
- 381
- References
- 31
- FWCI
- 66.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. https://app.cochat.ai/papers/10.1016/s0140-6736(16)00557-2
- The paper
- Lawson, J. H., Glickman, M. H., Ilzecki, M., Jakimowicz, T., Jaroszynski, A., Peden, E. K., Pilgrim, A. J., Prichard, H. L., Guziewicz, M., Przywara, S., Szmidt, J., Turek, J., Witkiewicz, W., Zapotoczny, N., Zubilewicz, T., & Niklason, L. E. (2016). Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. The Lancet. https://doi.org/10.1016/s0140-6736(16)00557-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.